2023_June_CIP_Geneva_skyscraper1

advanced search
2023_Dec_DDL_Edinburgh_leaderboard

Prefilled Syringes & Injection Devices101

Issue No #101 Oct 2019  October 2nd, 2019


Download PDF


Inside the magazine

SUCCESS FACTORS FOR THE YPSOMATE FAMILY OF AUTOINJECTORS
INJECTION
Orfeo Niedermann
Ypsomed
SUCCESS FACTORS FOR THE YPSOMATE FAMILY OF AUTOINJECTORS
Orfeo Niedermann looks at the key factors behind the growth and continued success of the YpsoMate family of two-step autoinjectors. He also introduces YpsoMate Design, which enables freeform outer shell design around the proven YpsoMate mechanism and manufacturing lines.
THE INTERFACE BETWEEN PREFILLED SYRINGE AND AUTOINJECTOR – A DEVELOPMENT FRAMEWORK
EXPERT VIEW
Dr Jeffrey Philippson
THE INTERFACE BETWEEN PREFILLED SYRINGE AND AUTOINJECTOR – A DEVELOPMENT FRAMEWORK
Jeffrey Philippson and Tom Kemp outline the challenges for autoinjector developers at the interface between the device and the prefilled syringe – and describe a framework to formalise analysis of the interface.
SIMPLIFYING THE PROCESS OF DEVELOPING PREFILLED SYRINGES
INJECTION
Tibor Hlobik
West Pharmaceutical Services
SIMPLIFYING THE PROCESS OF DEVELOPING PREFILLED SYRINGES
Tibor Hlobik describes how the use of cyclic olefin polymer delivery systems is gaining in popularity because of the benefits they have over glass systems for complex drug applications, and explains what this advance in technology can offer drug manufacturers.
30 YEARS IN THE MAKING – AN INSIDE PERSPECTIVE ON THE EMERGENCE OF AUTOINJECTORS
INJECTION
Michael McGowan
SHL Medical
30 YEARS IN THE MAKING – AN INSIDE PERSPECTIVE ON THE EMERGENCE OF AUTOINJECTORS
Michael McGowan, Director of Market Intelligence at SHL Group, gives a perspective on the emergence of the autoinjector as a key component of the drug delivery industry, in the context of SHL celebrating its 30th anniversary this year – a journey of rapid development that reflects the growing demand for advanced drug delivery systems in the healthcare market. 
DEVELOPMENTS IN SELF-INJECTION DEVICES FOR COMBINATION PRODUCTS
INJECTION
Dr Fred Metzmann
Haselmeier
DEVELOPMENTS IN SELF-INJECTION DEVICES FOR COMBINATION PRODUCTS
Fred Metzmann reports on the latest state-of-the-art developments in innovative injection devices for combination products in subcutaneous self-application. He outlines Haselmeier's product platform strategy for single-use (D-Flex) and re-usable (i-pen²) injection-pen systems, and related services and looks at the company’s connected digital solutions.
LED-GENERATED UV FOR ADHESIVE CURING IN MEDICAL DEVICES
PREFILLED SYRINGES
Roland Lindner
sortimat
LED-GENERATED UV FOR ADHESIVE CURING IN MEDICAL DEVICES
Roland Lindner, Matthias Schulze and Bill Jaworski discuss how the needs around adhesive use in the manufacture of medical devices such as glass syringes have evolved and how ATS sortimat has developed a new process to meet industry demands.
F2V: A STERILE, CUSTOMISABLE LIQUID FILL-FINISH PLATFORM FOR THE TOTAL LIFECYCLE
INDUSTRIALISATION
Simon Strothers
3P Innovation
F2V: A STERILE, CUSTOMISABLE LIQUID FILL-FINISH PLATFORM FOR THE TOTAL LIFECYCLE
Simon Strothers presents an integrated fill-finish platform, F2V, designed to represent a commercial filling system as a bench-top solution. The article also includes a recent case study where the F2V was used by Consort Medical to help develop and industrialise a flagship delivery device. 
PATIENTS, MANUFACTURERS & PRACTITIONERS CAN LEAD ADOPTION OF CONNECTED COMBINATION PRODUCTS
EXPERT VIEW
Napoleon Monroe
PATIENTS, MANUFACTURERS & PRACTITIONERS CAN LEAD ADOPTION OF CONNECTED COMBINATION PRODUCTS
Napoleon Monroe asks why connectivity has failed to advance rapidly, and argues that many stakeholders can benefit if the adoption of connectivity for drug delivery can be accelerated. While this article will centre on pharmaceutical combination products, the essential points also relate more broadly to pharmaceuticals and medical devices.
ASSESSING USABILITY EARLY FOR OPTIMAL INJECTION PEN DESIGN
INJECTION
David Fink
Ximedica
ASSESSING USABILITY EARLY FOR OPTIMAL INJECTION PEN DESIGN
David Fink and Stefan Gaul use the example of Haselmeier’s D-Flex system to explain why it is important to undertake a full use-related risk analysis for injection pen products to assess their usability and identify any risks, highlighting the importance of considering usability right from the start.
LATEST UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
PREFILLED SYRINGES
Tomohiro Suzuki
Mitsubishi Gas Chemical
LATEST UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
Tomohiro Suzuki gives an update on the development of the OXYCAPT™ multilayer plastic vial and syringe – highlighting the results of recent tests comparing it with existing glass syringes.
Z.BLIZZARD AUTOMATION SYSTEM FOR PFS: IMPROVING THE LIVES OF PATIENTS
INDUSTRIALISATION
Berthold Schopferer
Zahoransky
Z.BLIZZARD AUTOMATION SYSTEM FOR PFS: IMPROVING THE LIVES OF PATIENTS
With the ultimate objective of improving patients’ lives, Berthold Schopferer provides an overview of the company’s customer-specific automated manufacturing and assembly equipment offering for prefillable polymer syringes.
PRODUCT SHOWCASE: ZwickRoell Parenteral Device Testing Platform
INDUSTRIALISATION
Wolfgang Moersch
ZwickRoell
PRODUCT SHOWCASE: ZwickRoell Parenteral Device Testing Platform
ZwickRoell provides an overview of its parenteral device testing platform including roboTest, and associated software testXpert III and autoEdition3.
FUNCTION-BASED PRIMARY PACKAGING DESIGN FOR INJECTING VISCOUS NON-NEWTONIAN FORMULATIONS
INJECTION
Marta Vilaplana
Oval Medical Technologies
FUNCTION-BASED PRIMARY PACKAGING DESIGN FOR INJECTING VISCOUS NON-NEWTONIAN FORMULATIONS
Marta Vilaplana; Alex Vasiev and Susie White explore the challenges of delivering high-viscosity, non-Newtonian fluids emphasising the importance of robust tools to characterise specific device and formulation parameters in light of increasing regulatory scrutiny.
8 MM NEEDLE – IMPROVING SUBCUTANEOUS CHRONIC DRUG DELIVERY
PREFILLED SYRINGES
Aurelie Pager
BD (Becton Dickinson & Company)
8 MM NEEDLE – IMPROVING SUBCUTANEOUS CHRONIC DRUG DELIVERY
Aurelie Pager describes how reducing needle length can improve the risk profile of subcutaneous injections and can make injecting viscous formulations easier and quicker, and highlights BD’s development programme for an innovative shorter needle with ultra-thin walls for prefilled syringes.
CO-PACKAGED COMPONENTS IMPROVE PATIENT EXPERIENCE AND ENSURE CONSISTENT DRUG DELIVERY
EXPERT VIEW
Chris Franzese
Matchstick
CO-PACKAGED COMPONENTS IMPROVE PATIENT EXPERIENCE AND ENSURE CONSISTENT DRUG DELIVERY
Chris Franzese and Amy Rinaldi explore the challenges and benefits of co-packaging for manufacturers, healthcare workers and patients.
HOW CONNECTIVITY ADDS VALUE TO INJECTABLE DRUG DELIVERY DEVICES
CONNECTIVITY
Dr Iain Simpson
Phillips-Medisize
HOW CONNECTIVITY ADDS VALUE TO INJECTABLE DRUG DELIVERY DEVICES
In the context of the growing shift in emphasis from improving adherence to the better outcomes that can arise from doing so, Iain Simpson discusses why connectivity is becoming increasingly important in injectable drug delivery, and how it can benefit patients, providers and pharmaceutical manufacturers.
ADDING VALUE TO PREFILLED SYRINGES: SAFETY AND CONNECTIVITY
CONNECTIVITY
Chantal Wierckx
Biocorp
ADDING VALUE TO PREFILLED SYRINGES: SAFETY AND CONNECTIVITY
Chantal Wierckx and Arnaud Guillet provide an update on Newguard™, Biocorp’s integrated safety device for prefilled syringes, and explore the possible advantages connectivity can bring in the context of traceability for anti-counterfeiting, in clinical trials and in vaccination campaigns.
DEVELOPING DEMONSTRATORS TO INCREASE PATIENT CONFIDENCE AND REDUCE ANXIETY
PREFILLED SYRINGES
Joe Reynolds
Noble
DEVELOPING DEMONSTRATORS TO INCREASE PATIENT CONFIDENCE AND REDUCE ANXIETY
Joe Reynolds discusses the value of demonstrators for making patients comfortable and effective with their prefilled syringe, leading to a significant improvement in treatment adherence and patient quality of life.
Gerresheimer Expands Gx RTF<sup>®</sup> ClearJect<sup>®</sup> Product Line
PREFILLED SYRINGES
Mr Maximilian Vogl
Gerresheimer
Gerresheimer Expands Gx RTF® ClearJect® Product Line
Maximilian Vogl describes how Gerresheimer is expanding its range of prefillable polymer syringes to include a new product: the Gx RTF® ClearJect® polymer syringe, 2.25 mL.
Top